Skip to main content
FENC logo

FENC · Fennec Pharmaceuticals Inc. · Analyst Estimates

Track FENC — free
$10.65 -0.15 (-1.39%) At close · Sep 30
Market Cap
$371.89M
Shares
35.07M
Volume · Sep 30 149.22K Avg daily vol (3M) 198.99K

Analyst Estimates

Compare analyst forecasts for Fennec Pharmaceuticals Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 07:01 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.2
0.322
0.52
—
0.296
0.296
0.334
0.296
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
0
0
4
4
Revenue
USD
Publication date not stated
71044000
72564170
74000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.63
0.948
1.42
—
0.89
0.89
0.952
0.89
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
1
1
3
3
Revenue
USD
Publication date not stated
90700000
103110330
108500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.06
0.106
0.16
—
0.112
0.112
0.114
0.112
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
1
1
1
1
Revenue
USD
Publication date not stated
18208000
18908500
19600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.09
0.138
0.22
—
0.148
0.148
0.144
0.148
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
1
1
1
1
Revenue
USD
Publication date not stated
19854000
20684830
21500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —
Key facts CIK 1211583 CUSIP 31447P100 13F (30d) 3 filings 3 filers Visit website Investor relations